Target Name: LOC105378058
NCBI ID: G105378058
Review Report on LOC105378058 Target / Biomarker Content of Review Report on LOC105378058 Target / Biomarker
LOC105378058
Other Name(s): LOC105378058 variant X1 | Uncharacterized LOC105378058, transcript variant X1

LOC105378058: A Potential Drug Target for various Diseases

LOC105378058 (LOC105378058 variant X1) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the same family of proteins as the transmembrane protein ZNF211 and has been implicated in a number of cellular processes, including cell signaling, cell adhesion, and transcriptional regulation.

Recent studies have identified LOC105378058 as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because LOC105378058 has been shown to play a role in the regulation of cellular processes that are implicated in the development and progression of these diseases.

One of the key mechanisms by which LOC105378058 is thought to contribute to disease development is its role in the regulation of stem cell proliferation and differentiation. Stem cells are a vital source of repair and regeneration in the body and are involved in the development and maintenance of tissues throughout the lifespan. However, abnormal stem cell division and differentiation may lead to tumor formation. LOC105378058 has been shown to regulate the stem cell fate by controlling the expression of genes involved in cell proliferation and differentiation.

Another key mechanism by which LOC105378058 may contribute to disease development is its role in the regulation of neurotransmitter signaling. Neurotransmitters are essential for the communication of signals between neurons and are involved in a wide range of physiological processes, including mood regulation, learning, and memory . LOC105378058 has been shown to play a role in the regulation of neurotransmitter signaling by controlling the expression of genes involved in neurotransmitter synthesis, release, and uptake.

In addition to its role in stem cell biology and neurotransmission, LOC105378058 has also been shown to play a role in the regulation of cell adhesion and tissue repair. Adhesion is the process by which cells stick together to form tissues and organs. to regulate cell adhesion by controlling the expression of genes involved in cell adhesion and tight junctions, which are specialized structures that mediate cell-cell and cell-tissue interactions.

LOC105378058 has also been shown to play a role in the regulation of gene expression and has been identified as a potential drug target for the treatment of neurodegenerative diseases. neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, are characterized by the progressive loss of neurons and their associated cognitive and motor impairments. LOC105378058 has been shown to play a role in the regulation of gene expression by controlling the expression of genes involved in neurodegenerative diseases.

In conclusion, LOC105378058 is a protein that has been shown to play a role in a number of cellular processes that are involved in the development and progression of various diseases. Its potential as a drug target makes it an attractive target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand the role of LOC105378058 in disease development and to develop effective treatments.

Protein Name: Uncharacterized LOC105378058, Transcript Variant X1

The "LOC105378058 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378058 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133 | LOC105379144